Several studies have reported an increase in the systemic levels of pro-inflammatory mediators such as TNF-α, along with components of the interleukin family, among patients with COVID-19 requiring intensive care unit (ICU) admission [43,44]. The gene discussed is TNF; the disease is COVID-19.